At present, the main GLP-1RAs drugs that have been marketed include liraglutide, exenatide, albiglutide and dulaglutide ( The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Osteoporosis Effects of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Osteoporosis Most patients with T2DM have normal bone density, but the risk of fracture is increased
The study found no increase in pancreatic cancer risk with GLP-1RA use, and several sensitivity analyses suggested a modest, non-significant reduction in incidence (Wang et al., 2025)
consider an over-the-counter fiber supplement if needed
That means hair loss was reported 2.46 times more frequently than the baseline expectation across all medications in the database
Yes, GLP-1-based therapies are FDA-recommended for weight loss, particularly in individuals with a BMI over 30 or those who did not have success with other weight-loss methods